Peptides DB
Research-centric peptide and protocol reference hub
Study 4 of 29MOTS-C literaturePubMed · Observational2026

Circulating mitochondrial-derived microproteins at rest and in response to an acute bout of endurance exercise in individuals with cerebral palsy.

Individuals with cerebral palsy show similar levels of mitochondrial-derived microproteins as typically developing individuals, suggesting preserved signaling despite differences in physical fitness.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the mots-c corpus
13
Preclinical
13
Observational · this one
0
Open-label
1
Randomised
2
Reviews

Summary and findings

This study examined circulating mitochondrial-derived microproteins (MDPs) in individuals with cerebral palsy (CP) compared to typically developing (TD) individuals at rest and after exercise. The groups included TD adults (n=10, age 31 ± 6 years), TD adolescents (n=10, age 16 ± 1 years), and adults with CP (n=10, age 25 ± 6 years). No significant differences in MDP levels were observed between CP and TD individuals post-exercise.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as PubMed supplied them

Regular exercise using assistive movement devices, such as running frames, has emerged as a promising strategy to improve cardiorespiratory fitness in individuals with cerebral palsy (CP). However, the molecular pathways underlying these adaptations remain poorly understood. Here, we examined a novel class of signalling molecules, mitochondrial-derived microproteins (MDPs), and assessed whether individuals with CP exhibit altered circulating levels compared with typically developing (TD) individuals at rest and following an acute bout of endurance exercise. Three groups were included: TD adults (31 ± 6 years), TD adolescents (16 ± 1 years) and adults with CP (25 ± 6 years). Individuals with CP were classified as Gross Motor Function Classification System (GMFCS) levels II-IV and had at least 3 months of frame running experience. Habitual physical activity, ultrasound-derived muscle thickness, and peak oxygen uptake were assessed. The exercise session consisted of 45 min of frame running for individuals with CP and conventional running for TD participants. Blood samples were obtained before and 1 h after exercise, and plasma MDP concentrations were measured using in-house enzyme-linked immunosorbent assay. Adults with CP had reduced muscle mass and maximal oxygen uptake compared to TD individuals. Despite this, they exhibited basal circulating levels of MDPs, including humanin, MOTS-c and SHMOOSE, comparable to TD adults and adolescents, with no associations with CP subtype or motor impairment severity. Following exercise, circulating MDPs showed no or only modest changes across groups, with no differences between CP and TD individuals. Overall, these findings suggest preserved mitochondrial-derived signalling via MDPs in individuals with CP.

Background

The paper investigates the role of circulating mitochondrial-derived microproteins in individuals with cerebral palsy, a population known to have altered mitochondrial function. Prior research has established the importance of mitochondrial health in various conditions, but specific data on microproteins in this demographic is limited. Understanding these microproteins may provide insights into metabolic responses and adaptations in individuals with cerebral palsy.

Methods

The study design and specific methodologies, including population characteristics, sample size, dosing regimens, and duration of the intervention, were not reported in the abstract. Primary and secondary outcome measures related to the microproteins were also not detailed.

Results

The results section did not provide specific numeric findings or statistical analyses in the abstract. Therefore, no primary endpoint data, effect sizes, or p-values are available for review.

Interpretation

Due to the lack of reported results, it is not possible to compare the findings to prior literature or assess the clinical significance of any observed effects. The absence of detailed data limits the ability to draw conclusions about the implications for practice or the relevance of the findings in the context of existing research.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the MOTS-C corpus

DMOTS-c in sepsis-induced cardiomyopathy: Mechanisms and translational potential.European journal of pharmacology · 2026reviewBUnusual aspect of cuticular morphology in human pulmonary dirofilariasis.Parasitology international · 2026 · Not reported in abstract.HumanCFirst detection of a Haemoproteus macrovacuolatus-like parasite in two captive birds of the order Anseriformes: Evidence of atypical morphology.Parasitology international · 2026 · 100% similarity to Haemoproteus macrovacuolatus based on a 478 bp fragment.AnimalCEffects of F/2 medium variations on parasitic green microalgae Coccomyxa parasitica: Short-term morphofunctional adaptations.Parasitology international · 2026 · 60% increase in cell density in 2F medium within 48 h.In vitroDIssues of species identification within Paramphistomoidea Fischoeder, 1911 (Trematoda).Parasitology international · 2026 · Not reported in abstract.CTrojan horse-inspired vaccine-like nanoparticle with enhanced lubrication and active-passive synergistic anti-inflammation for post-traumatic osteoarthritis treatment.Bioactive materials · 2026 · OARSI score reduced by more than 80% in a 4-week rat PTOA model.Animal